Clonidine in Patients Undergoing Noncardiac Surgery

PJ Devereaux; DI Sessler; K Leslie; A Kurz; M Mrkobrada; P Alonso-Coello; JC Villar; A Sigamani; BM Biccard; CS Meyhoff; JL Parlow; G Guyatt; A Robinson; AX Garg; RN Rodseth; F Botto; G Lurati Buse; D Xavier; MTV Chan; M Tiboni; D Cook; PA Kumar; P Forget; G Malaga; E Fleischmann; M Amir; J Eikelboom; R Mizera; D Torres; CY Wang; T VanHelder; P Paniagua; O Berwanger; S Srinathan; M Graham; L Pasin; Y Le Manach; P Gao; J Pogue; R Whitlock; A Lamy; C Kearon; C Chow; S Pettit; S Chrolavicius; S Yusuf

Journal article

Clonidine in Patients Undergoing Noncardiac Surgery

PJ Devereaux, DI Sessler, K Leslie, A Kurz, M Mrkobrada, P Alonso-Coello, JC Villar, A Sigamani, BM Biccard, CS Meyhoff, JL Parlow, G Guyatt, A Robinson, AX Garg, RN Rodseth, F Botto, G Lurati Buse, D Xavier, MTV Chan, M Tiboni Show all

New England Journal of Medicine | MASSACHUSETTS MEDICAL SOC | Published : 2014

DOI: 10.1056/NEJMoa1401106

University of Melbourne Researchers

Kate Leslie Author Melbourne Medical School

Grants

Funding Acknowledgements

Supported by grants from the Canadian Institutes of Health Research, the Commonwealth Government of Australia's National Health and Medical Research Council, the Spanish Ministry of Health and Social Policy, and Boehringer Ingelheim. Bayer Pharma provided the aspirin study drug, and Boehringer Ingelheim the clonidine study drug.